Jillian Perez, PA
Physician Assistant · East Haven, CTNPI 1265691620
Payments from drug & device makers
Across 99 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$558
- GSK$103
- Lilly USA, LLC$86
- Novo Nordisk$81
- Amgen$58
- Merck$57
- plus $505 from 18 others
What the payments were for
- Food & beverage$1,42899%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $558 |
| GSK | 6 | $103 |
| Lilly USA, LLC | 4 | $86 |
| Novo Nordisk | 5 | $81 |
| Amgen | 3 | $58 |
| Merck | 4 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Boehringer Ingelheim | 2 | $45 |
| AstraZeneca | 3 | $44 |
| Bayer | 2 | $41 |
| USWM, LLC | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 5 | $35 |
| Amarin Pharma, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Bausch Health US, LLC | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Pfizer | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Abbott | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
How this compares
$1,448 in reported general payments places this provider in the 80th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 85 | $90,099 |
| MounjaroTirzepatide | 66 | $89,865 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 101 | $75,124 |
| EliquisApixaban | 53 | $45,507 |
| JardianceEmpagliflozin | 41 | $38,983 |
| FarxigaDapagliflozin Propanediol | 17 | $19,118 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $15,512 |
| LinzessLinaclotide | 17 | $13,445 |
| XareltoRivaroxaban | 21 | $12,891 |
| JanuviaSitagliptin Phosphate | 14 | $12,639 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $12,145 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 35 | $10,558 |
| VascepaIcosapent Ethyl | 14 | $9,677 |
| LivaloPitavastatin Calcium | 22 | $9,125 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 14 | $8,296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Arnuity Ellipta, Breo Ellipta | $103 | $111,446193 claims |
| Novo NordiskOzempic | $81 | $90,09985 claims |
| Lilly USA, LLCMounjaro | $86 | $89,86566 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $45 | $51,02263 claims |
| PfizerEliquis | $21 | $45,50753 claims |
| MerckJanumet, Januvia, Janumet Xr | $57 | $36,44741 claims |
| AstraZenecaFarxiga, Symbicort | $44 | $23,65934 claims |
| AbbVieLinzess, Synthroid | $558 | $14,67430 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $15 | $9,12522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in East Haven
- Jenna LangelloWaterbury$345K
- Gary SpinnerBridgeport$123K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
- Kristine LaneMiddletown$30K
- Kathryn MidgleyNew Haven$28K
- Richard MoroPlainfield$25K
- Janine TedescoDarien$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.